EUVIMEDEUVIMED entdecken
Open Access

Hepatic Inactivation of Carnitine Palmitoyltransferase 1a Lowers ApoB-Containing Lipoproteins in Mice

Robert N Helsley iD, Mikala M Zelows iD, Victoria P Noffsinger, Garrett B Anspach, Nikitha Dharanipragada, Anna E Mead, Isidoro Cobo iD, Abigail Carter, Qinglin Wu, Irina Shalaurova iD, Kai Saito, Josh M Morganti iD und 2 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.125.322473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Robert N Helsley und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine (R.N.H., M.M.Z., G.B.A., N.D.), University of Kentucky, Lexingto…. Hauptthemen laut MEDLINE: Carnitine O-Palmitoyltransferase, Liver, Apolipoprotein B-100, Dyslipidemias. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Genome- and epigenome-wide association studies have associated variants and methylation status of CPT1a (carnitine palmitoyltransferase 1a) to reductions in VLDL (very low-density lipoprotein) cholesterol and triglyceride levels. The objective of this study was to determine the mechanisms by which CPT1a-dependent mitochondrial fatty acid oxidation influences hepatic and lipoprotein metabolism. METHODS: Eight-week-old male and female Cpt1a -floxed mice ( Cpt1a fl/fl ) and Cpt1a -floxed mice expressing the human apo B 100 transgene ( Cpt1a fl/fl /B100 Tg ) were administered control adeno-associated virus or adeno-associated virus encoding Cre-recombinase under control of a liver-specific promoter (TBG-Cre [thyroxin-binding globulin]). Control and liver-specific knockout mice were placed on a low-fat control or western-type diet (42% kcal fat, 0.2% cholesterol) for 16 weeks. Livers were collected and used for histological and lipid analysis, while gene and protein expression were measured by bulk RNA-sequencing and immunoblotting, respectively. Lipoprotein composition in plasma was determined by size exclusion chromatography and nuclear magnetic resonance. Rates of VLDL-triglyceride secretion were quantified after lipase inhibition with poloxamer 407. Liquid and gas chromatography–mass spectrometry were used to measure bile acid species and fecal neutral sterols, respectively. RESULTS: We report significant associations between the presence of CPT1a SNPs (single nucleotide polymorphisms) and reductions in plasma cholesterol, as well as positive associations between hepatic Cpt1a expression and plasma cholesterol levels across inbred mouse strains. Mechanistic studies show that both wild-type and human apo B 100 (apoB)–transgenic mice with liver-specific deletion of Cpt1a (liver-specific knockout) display lower circulating apoB levels consistent with reduced LDL (low-density lipoprotein)-cholesterol and LDL particle number. Despite a reduction in steady-state plasma lipids, VLDL-triglyceride and VLDL cholesterol secretion rates are increased, suggesting accelerated clearance of apoB-LPs (apoB-containing lipoproteins) in liver-specific knockout mice. Mechanistic approaches show greater PPARα (peroxisome proliferator–activated receptor α) signaling which favors enhanced lipoprotein lipase–mediated metabolism of apoB-LPs, including increases in apo AIV and apo CII and reductions in apo CIII and Angptl3 (angiopoietin-like 3). CONCLUSIONS: These studies provide mechanistic insight linking genetic variants and methylation status of CPT1a to reductions in circulating apoB-LPs in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carnitine O-PalmitoyltransferaseLiverApolipoprotein B-100DyslipidemiasAnimalsMaleFemaleMice, KnockoutMiceHumansMice, Inbred C57BLTriglyceridesDiet, WesternPPAR alphaLipoproteins, VLDLMitochondria, LiverFatty AcidsDiet, Fat-RestrictedPhenotypeOxidation-Reduction

Stichwörter der Autor:innen

cardiovascular diseasesfatty acidslipolysislipoproteinsmitochondria

Substanzen

Carnitine O-PalmitoyltransferaseApolipoprotein B-100Triglyceridesvery low density lipoprotein triglyceridePPAR alphaLipoproteins, VLDLApob protein, mouseFatty AcidsPpara protein, mouse

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine (R.N.H., M.M.Z., G.B.A., N.D.), University of Kentucky, Lexington.
  • Department of Pharmacology and Nutritional Sciences (R.N.H., G.B.A., N.D.), University of Kentucky, Lexington.
  • Department of Physiology (R.N.H., V.P.N., G.B.A.,N.D., A.E.M., A.C., S.M.G., G.A.G.), University of Kentucky, Lexington.
  • Barnstable Brown Diabetes Center (R.N.H., G.B.A., N.D., G.A.G.), University of Kentucky, Lexington.
  • Markey Cancer Center (R.N.H., G.B.A., N.D.), University of Kentucky, Lexington.
  • Saha Cardiovascular Research Center (R.N.H., M.M.Z., V.P.N., G.B.A., N.D., A.E.M., A.C., S.M.G., G.A.G.), University of Kentucky, Lexington.

ORCID-Profile: Robert N Helsley, Mikala M Zelows, Isidoro Cobo, Irina Shalaurova, Josh M Morganti, Scott M Gordon, Gregory A Graf

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Helsley, R. N., Zelows, M. M., Noffsinger, V. P., Anspach, G. B., Dharanipragada, N., Mead, A. E., Cobo, I., Carter, A., Wu, Q., Shalaurova, I., Saito, K., Morganti, J. M., Gordon, S. M., & Graf, G. A. (2025). Hepatic Inactivation of Carnitine Palmitoyltransferase 1a Lowers ApoB-Containing Lipoproteins in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.322473

Vancouver

Helsley RN, Zelows MM, Noffsinger VP, Anspach GB, Dharanipragada N, Mead AE, et al. Hepatic Inactivation of Carnitine Palmitoyltransferase 1a Lowers ApoB-Containing Lipoproteins in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.125.322473

BibTeX
@article{Helsley2025,
  author = {Helsley, Robert N and Zelows, Mikala M and Noffsinger, Victoria P and Anspach, Garrett B and Dharanipragada, Nikitha and Mead, Anna E and Cobo, Isidoro and Carter, Abigail and Wu, Qinglin and Shalaurova, Irina and Saito, Kai and Morganti, Josh M and Gordon, Scott M and Graf, Gregory A},
  title = {Hepatic Inactivation of Carnitine Palmitoyltransferase 1a Lowers ApoB-Containing Lipoproteins in Mice},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.125.322473}
}
Kostenlos starten →